SCHEMBL26437709

SCHEMBL26437709

CCOC(=O)Cn1nc(C(F)(F)F)c2c1C(=O)C(C)C2

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TRPM2 O94759 1/20 0.40
▸ LMNA P02545 3/20 0.38
▸ POLB P06746 1/20 0.38
▸ TSHR P16473 3/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ CYP2C19 P33261 2/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ GAA P10253 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20756450 0.89 TRPM2 (0.41) TRPM2LMNAPOLBTSHRNPSR1
SCHEMBL14555812 0.80 TRPM2 (0.44) TRPM2LMNAPOLBTSHRNPSR1
SCHEMBL15724335 0.78 TRPM2 (0.47) TRPM2LMNAPOLBTSHRNPSR1
SCHEMBL21420050 0.77 POLB (0.38) TRPM2POLBTSHRCYP2C19CYP2C9
SCHEMBL21420046 0.77 POLB (0.40) TRPM2POLBTSHRCYP2C19CYP2C9
SCHEMBL21420079 0.77 POLB (0.38) TRPM2POLBTSHRCYP2C19CYP2C9
SCHEMBL14487702 0.77 POLB (0.40) TRPM2POLBTSHRCYP2C19CYP2C9
SCHEMBL26251001 0.77 POLB (0.40) TRPM2POLBTSHRCYP2C19CYP2C9
SCHEMBL26437685 0.76 TRPM2 (0.39) TRPM2LMNAPOLBTSHRNPSR1
SCHEMBL14487805 0.75 TRPM2 (0.47) TRPM2LMNAPOLBTSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4253366-A2 METHODS AND INTERMEDIATES FOR PREPARING A THERAPEUTIC COMPOUND USEFUL IN THE TREATMENT OF RETROVIRIDAE VIRAL INFECTION Gilead Sciences, Inc. (US) 2023-10-04 — — EP disclosed
Send feedback